TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,264,639 | -9.0% | 390,507 | +170.3% | 0.08% | -12.8% |
| Q2 2023 | $3,589,007 | -21.5% | 144,485 | -62.6% | 0.09% | -27.7% |
| Q4 2022 | $4,571,905 | +2087.5% | 386,467 | +992.7% | 0.13% | +1757.1% |
| Q3 2022 | $209,000 | -54.7% | 35,369 | -14.8% | 0.01% | -74.1% |
| Q4 2019 | $461,000 | +62.9% | 41,522 | +92.9% | 0.03% | +35.0% |
| Q2 2018 | $283,000 | -76.8% | 21,522 | -75.0% | 0.02% | -76.5% |
| Q1 2018 | $1,220,000 | +121.4% | 85,943 | +27.8% | 0.08% | +41.7% |
| Q4 2017 | $551,000 | +108.7% | 67,243 | +54.2% | 0.06% | +71.4% |
| Q2 2016 | $264,000 | -7.7% | 43,609 | +82.1% | 0.04% | +40.0% |
| Q4 2015 | $286,000 | -44.9% | 23,950 | -23.5% | 0.02% | -56.9% |
| Q2 2015 | $519,000 | – | 31,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |